The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...
A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S.
Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral ...
So, the UK government is considering reclassing ketamine as a Class A drug. The Home Office asked the Advisory Council on the ...
Researchers at the University of Virginia Brain Institute and UVA School of Medicine will conduct a trial to see if the ...
Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...
A massive drug bust in Flushing, Queens has led to the indictment of four individuals accused of running a dangerous ...
The Food and Drug Administration (FDA) has approved Spravato, a nasal spray developed by Johnson & Johnson, as a standalone ...
Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...
A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...